IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

(Investigative Ophthalmology and Visual Science. 2004;45:4049-4059.)
© 2004 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.04-0490
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (30)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tezel, G.
Right arrow Articles by Yang, X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tezel, G.
Right arrow Articles by Yang, X.

Caspase-Independent Component of Retinal Ganglion Cell Death, In Vitro

Gülgün Tezel1,2 and Xiangjun Yang1

1From the Departments of Ophthalmology and Visual Sciences and 2Anatomical Sciences and Neurobiology, University of Louisville School of Medicine, Louisville, Kentucky.

PURPOSE. Although in vitro and in vivo models demonstrate caspase activation in retinal ganglion cells (RGCs) undergoing apoptosis, the caspase-independent component of RGC death is unclear. Identification of the precise mechanisms of cell death in these distinct neurons is essential for the development of effective neuroprotective strategies in glaucoma. Because TNF-{alpha} and hypoxia have been implicated in RGC death during glaucomatous optic nerve degeneration, this study was conducted to determine whether RGCs survive exposure to TNF-{alpha} or hypoxia in the presence of caspase inhibitor treatment, and whether mitochondrial dysfunction is involved in RGC death induced by these glaucomatous stimuli.

METHODS. Primary cultures of rat RGCs were exposed to TNF-{alpha} or hypoxia for up to 48 hours. The temporal relationship of RGC death with the loss of mitochondrial membrane potential and the release of cell death mediators, including cytochrome c and apoptosis-inducing factor (AIF), was studied in the absence and presence of specific inhibitors of caspases. In addition, treatment with a free-radical scavenger, 4-hydroxytetramethylpiperidine-1-oxyl (tempol; 5 mM), was used in some experiments. Cell viability was assessed using calcein assay, and annexin V binding combined with propidium iodide staining was used for the distinction of apoptotic and necrotic cells. Caspase-3–like protease activity was measured using a fluorometric assay, and for the in situ detection of caspase activity, immunocytochemistry was performed with a cleavage-site–specific antibody. The time course of alterations in the mitochondrial membrane potential and the release of cell death mediators in individual cells undergoing cell death were assessed with a fluorescent tracer and subsequent immunocytochemistry. In addition, a fluorescent dye, dihydroethidium was used to assess the generation of reactive oxygen species (ROS).

RESULTS. Findings of this study revealed that the loss of mitochondrial membrane potential and the release of cell death mediators accompanied RGC death induced by TNF-{alpha} or hypoxia. Although caspase inhibitor treatment temporarily decreased the rate of apoptosis, caspase inhibition was not adequate to block RGC death if the mitochondrial membrane potential was lost and mitochondrial mediators were released. Despite the inhibited caspase activity, survival rate was less than 70% after a 48-hour incubation with death stimuli, and both apoptotic and necrotic cells were detectable in these cultures. When combined with caspase inhibition, tempol reduced the production of ROS and provided an additional 20% increase in RGC survival.

CONCLUSIONS. Based on these novel findings, RGC death induced by TNF-{alpha} or hypoxia involves a caspase-independent component, and reducing the free-radical generation provides additional protection of RGCs temporarily saved by caspase inhibition. Therefore, neuroprotective strategies in glaucoma should include tools to improve the ability of these neurons to survive the cytotoxic consequences of mitochondrial dysfunction.




This article has been cited by other articles:


Home page
 IOVSHome page
S. Berger, S. I. Savitz, S. Nijhawan, M. Singh, J. David, P. S. Rosenbaum, and D. M. Rosenbaum
Deleterious Role of TNF-{alpha} in Retinal Ischemia-Reperfusion Injury
Invest. Ophthalmol. Vis. Sci., August 1, 2008; 49(8): 3605 - 3610.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
X. Yang, C. Luo, J. Cai, W. M. Pierce, and G. Tezel
Phosphorylation-Dependent Interaction with 14-3-3 in the Regulation of Bad Trafficking in Retinal Ganglion Cells
Invest. Ophthalmol. Vis. Sci., June 1, 2008; 49(6): 2483 - 2494.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
G. Tezel, X. Yang, C. Luo, Y. Peng, S. L. Sun, and D. Sun
Mechanisms of Immune System Activation in Glaucoma: Oxidative Stress-Stimulated Antigen Presentation by the Retina and Optic Nerve Head Glia
Invest. Ophthalmol. Vis. Sci., February 1, 2007; 48(2): 705 - 714.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
R. M. Sappington and D. J. Calkins
Pressure-Induced Regulation of IL-6 in Retinal Glial Cells: Involvement of the Ubiquitin/Proteasome Pathway and NF{kappa}B.
Invest. Ophthalmol. Vis. Sci., September 1, 2006; 47(9): 3860 - 3869.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
C. R. Schlieve, C. J. Lieven, and L. A. Levin
Biochemical activity of reactive oxygen species scavengers do not predict retinal ganglion cell survival.
Invest. Ophthalmol. Vis. Sci., September 1, 2006; 47(9): 3878 - 3886.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
R. M. Sappington, M. Chan, and D. J. Calkins
Interleukin-6 protects retinal ganglion cells from pressure-induced death.
Invest. Ophthalmol. Vis. Sci., July 1, 2006; 47(7): 2932 - 2942.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
K. K. Abu-Amero, J. Morales, and T. M. Bosley
Mitochondrial abnormalities in patients with primary open-angle glaucoma.
Invest. Ophthalmol. Vis. Sci., June 1, 2006; 47(6): 2533 - 2541.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
D. P. McKernan, C. Caplis, M. Donovan, C. J. O'Brien, and T. G. Cotter
Age-dependent susceptibility of the retinal ganglion cell layer to cell death.
Invest. Ophthalmol. Vis. Sci., March 1, 2006; 47(3): 807 - 814.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
E. M. Kniep, C. Roehlecke, N. Ozkucur, A. Steinberg, F. Reber, L. Knels, and R. H. W. Funk
Inhibition of Apoptosis and Reduction of Intracellular pH Decrease in Retinal Neural Cell Cultures by a Blocker of Carbonic Anhydrase.
Invest. Ophthalmol. Vis. Sci., March 1, 2006; 47(3): 1185 - 1192.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
G. Tezel, X. Yang, and J. Cai
Proteomic Identification of Oxidatively Modified Retinal Proteins in a Chronic Pressure-Induced Rat Model of Glaucoma
Invest. Ophthalmol. Vis. Sci., September 1, 2005; 46(9): 3177 - 3187.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the Association for Research in Vision and Ophthalmology